Epidemiology and prevention of cardiovascular complication in chronic kidney disease patients

被引：14
|
作者：
Pozzoni, P [1 ]
Pozzi, M [1 ]
Del Vecchio, L [1 ]
Locatelli, F [1 ]
机构：
[1] A Manzoni Hosp, Dept Nephrol & Dialysis, I-23900 Lecce, Italy
来源：
SEMINARS IN NEPHROLOGY | 2004年 / 24卷 / 05期
关键词：
chronic kidney disease; cardiovascular disease; end-stage renal disease; anemia; hyperphosphatemia; dyslipidemia; inflammation; oxidative stress;
D O I：
10.1016/j.semnephrol.2004.06.012
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：417 / 422
页数：6
相关论文
共 50 条
  • [21] Cardiovascular disease in patients with chronic kidney disease
    Pilmore, Helen
    Dogra, Gursharan
    Roberts, Matthew
    Heerspink, Hiddo J. Lambers
    Ninomiya, Toshiharu
    Huxley, Rachel
    Perkovic, Vlado
    NEPHROLOGY, 2014, 19 (01) : 3 - 10
  • [22] Cardiovascular disease in patients with chronic kidney disease
    Marx, Nikolaus
    Floege, Juergen
    HERZ, 2021, 46 (03) : 205 - 205
  • [23] Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis
    Levin, A
    SEMINARS IN DIALYSIS, 2003, 16 (02) : 101 - 105
  • [24] Roadmap for cardiovascular prevention trials in chronic kidney disease
    Rossignol, Patrick
    Pitt, Bertram
    Thompson, Aliza
    Zannad, Faiez
    LANCET, 2016, 388 (10055): : 1964 - 1966
  • [25] Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention (vol 381, pg 339, 2013)
    Gansevoort, R. T.
    Correa-Rotter, R.
    Hemmelgarn, B. R.
    LANCET, 2013, 382 (9889): : 310 - 310
  • [26] Sudden cardiac death in chronic kidney disease: epidemiology and prevention
    Shamseddin, M. Khaled
    Parfrey, Patrick S.
    NATURE REVIEWS NEPHROLOGY, 2011, 7 (03) : 145 - 154
  • [27] Sudden cardiac death in chronic kidney disease: epidemiology and prevention
    M. Khaled Shamseddin
    Patrick S. Parfrey
    Nature Reviews Nephrology, 2011, 7 : 145 - 154
  • [28] Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease
    Hadar Haim-Pinhas
    Gil Yoskovitz
    Michael Lishner
    David Pereg
    Yona Kitay-Cohen
    Guy Topaz
    Yaron Sela
    Ori Wand
    Ilan Rozenberg
    Sydney Benchetrit
    Keren Cohen-Hagai
    Scientific Reports, 12
  • [29] Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients
    Suliman, Mohamed E.
    Lindholm, Bengt
    Barany, Peter
    Qureshi, Abdul Rashid
    Stenvinkel, Peter
    SEMINARS IN DIALYSIS, 2007, 20 (06) : 523 - 529
  • [30] Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease
    Haim-Pinhas, Hadar
    Yoskovitz, Gil
    Lishner, Michael
    Pereg, David
    Kitay-Cohen, Yona
    Topaz, Guy
    Sela, Yaron
    Wand, Ori
    Rozenberg, Ilan
    Benchetrit, Sydney
    Cohen-Hagai, Keren
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345